Tiziana Life Sciences

TLSANasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$127.259 M

$1.00 +2.64%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

120,507,401

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#295NRX PharmaceuticalsNRXP$129.7M
#296Spruce BiosciencesSPRB$129.0M
#297Tiziana Life SciencesTLSA$127.3M
#298BGM GroupBGM$120.3M
#299GeneluxGNLX$119.3M

Where these numbers come from

Share counts and financials for Tiziana Life Sciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.